PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 62996

Fatal graft-versus-host disease following transfusion of granulocytes from normal donors.

J M Ford·M H Cullen·J J Lucey·J S Tobias·T A Lister
View original source ↗Export metadata ↓

Abstract

A case of fatal graft-versus-host disease was seen in an adult with acute leukaemia, after transfusion of leucocytes from normal donors. This is the first reported case of graft-versus-host disease following transfusion of normal blood-products to a patient with a disease not usually associated with severe immunoincompetence. The number of lymphocytes transfused was no higher than that given when platelet concentrates are prepared from a single donor.

Explore related subjects

Graft vs Host DiseaseGraft vs Host ReactionGranulocytesHumansLeukemia, Myeloid, AcuteLeukocytesLiverMaleMiddle AgedSkinTransfusion ReactionCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Ford, M H Cullen, J J Lucey, J S Tobias, T A Lister. 1976-11-27. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors.. https://doi.org/10.1016/s0140-6736(76)91682-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2024

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.

Acute lower gastrointestinal GVHD (aLGI-GVHD) is a serious complication of allogeneic hematopoietic stem cell transplantation. Although the intestinal microbiota is associated with the incidence of aLGI-GVHD, how the intestinal microbiota impacts treatment responses in aLGI-GVHD has not been thoroughly studied. In a cohort of patients with aLGI-GVHD (n = 37), we found that non-response to standard therapy with corticosteroids was associated with prior treatment with carbapenem antibiotics and a disrupted fecal microbiome characterized by reduced abundances of Bacteroides ovatus. In a murine GVHD model aggravated by carbapenem antibiotics, introducing B. ovatus reduced GVHD severity and improved survival. These beneficial effects of Bacteroides ovatus were linked to its ability to metabolize dietary polysaccharides into monosaccharides, which suppressed the mucus-degrading capabilities of colonic mucus degraders such as Bacteroides thetaiotaomicron and Akkermansia muciniphila, thus reducing GVHD-related mortality. Collectively, these findings reveal the importance of microbiota in aLGI-GVHD and therapeutic potential of B. ovatus.

Graft vs Host Disease↗